| Mark Henry Koets, MD | |
|
100 Michigan St Ne, Grand Rapids, MI 49503-2560 | |
| (616) 267-8244 | |
| (616) 391-3044 |
| Full Name | Mark Henry Koets |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 35 Years |
| Location | 100 Michigan St Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891735825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301054578 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Spectrum Health Gerber Memorial | Fremont, MI | Hospital |
| Spectrum Health Zeeland Community Hospital | Zeeland, MI | Hospital |
| Spectrum Health Big Rapids Hospital | Big rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
New peer-reviewed research published today in Drugs Education Prevention and Policy shows that e-cigarettes are not increasing the likelihood of tobacco consumption and may in fact be contributing to negative perceptions about smoking among young people.
Geriatric conditions such as frailty and cognitive impairments may inadvertently worsen when older patients are treated in cardiac intensive care units - even as they receive excellent care for their heart attack, heart failure, valvular heart disease or pulmonary embolism, according to a new scientific statement from the American Heart Association, published today in the Association's premier journal Circulation.
Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").
"The clear pattern of increasing antiretroviral resistance in lower-income settings must be considered in the context of the worldwide HIV-control agenda," especially because "the increasing rates of antiretroviral resistance in low-income settings represent a potential threat to the emerging treatment-as-prevention strategy," Evan Wood and Julio Montaner of the BC Centre for Excellence in HIV/AIDS write in a Lancet Infectious Diseases opinion piece.
In an editorial opening the 2006 Jan issue of Psychotherapy and Psychosomatics Giovanni A. fava (University of Bologna) criticizes the current subdivision of clinical medicine in subspecialties.
› Verified 3 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
New peer-reviewed research published today in Drugs Education Prevention and Policy shows that e-cigarettes are not increasing the likelihood of tobacco consumption and may in fact be contributing to negative perceptions about smoking among young people.
Geriatric conditions such as frailty and cognitive impairments may inadvertently worsen when older patients are treated in cardiac intensive care units - even as they receive excellent care for their heart attack, heart failure, valvular heart disease or pulmonary embolism, according to a new scientific statement from the American Heart Association, published today in the Association's premier journal Circulation.
Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").
"The clear pattern of increasing antiretroviral resistance in lower-income settings must be considered in the context of the worldwide HIV-control agenda," especially because "the increasing rates of antiretroviral resistance in low-income settings represent a potential threat to the emerging treatment-as-prevention strategy," Evan Wood and Julio Montaner of the BC Centre for Excellence in HIV/AIDS write in a Lancet Infectious Diseases opinion piece.
In an editorial opening the 2006 Jan issue of Psychotherapy and Psychosomatics Giovanni A. fava (University of Bologna) criticizes the current subdivision of clinical medicine in subspecialties.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Henry Koets, MD 100 Michigan St Ne, Mc845, Grand Rapids, MI 49503-2560 Ph: (616) 486-6790 | Mark Henry Koets, MD 100 Michigan St Ne, Grand Rapids, MI 49503-2560 Ph: (616) 267-8244 |
News Archive
New peer-reviewed research published today in Drugs Education Prevention and Policy shows that e-cigarettes are not increasing the likelihood of tobacco consumption and may in fact be contributing to negative perceptions about smoking among young people.
Geriatric conditions such as frailty and cognitive impairments may inadvertently worsen when older patients are treated in cardiac intensive care units - even as they receive excellent care for their heart attack, heart failure, valvular heart disease or pulmonary embolism, according to a new scientific statement from the American Heart Association, published today in the Association's premier journal Circulation.
Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").
"The clear pattern of increasing antiretroviral resistance in lower-income settings must be considered in the context of the worldwide HIV-control agenda," especially because "the increasing rates of antiretroviral resistance in low-income settings represent a potential threat to the emerging treatment-as-prevention strategy," Evan Wood and Julio Montaner of the BC Centre for Excellence in HIV/AIDS write in a Lancet Infectious Diseases opinion piece.
In an editorial opening the 2006 Jan issue of Psychotherapy and Psychosomatics Giovanni A. fava (University of Bologna) criticizes the current subdivision of clinical medicine in subspecialties.
› Verified 3 days ago
Maureen U Tan- Pedres, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Suite A721, Grand Rapids, MI 49503 Phone: 616-391-3139 Fax: 616-391-3044 | |
Jeffery Allen Woo, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1900 Wealthy St Se, Ste 150, Grand Rapids, MI 49506 Phone: 616-459-3158 Fax: 616-988-0071 | |
Robert W Selfe, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne, Suite 200, Grand Rapids, MI 49503 Phone: 616-267-8950 Fax: 616-267-8585 | |
Dr. Erin Megan Pettijohn, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 250 Cherry St Se Ste 2200, Grand Rapids, MI 49503 Phone: 616-685-5600 | |
Dr. Andrew Leo Sochacki, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5800 Foremost Dr Se Ste 200, Grand Rapids, MI 49546 Phone: 616-389-1800 | |
Stephanie F Williams, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 5200, Grand Rapids, MI 49503 Phone: 616-486-5933 Fax: 616-486-6489 | |
Simin Beg, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 145 Michigan St Ne Ste 3410, Grand Rapids, MI 49503 Phone: 616-391-9945 |